文献速递糖尿病肥胖与代谢综合征

糖尿病前期成人血清25-羟维生素D浓度与死亡率的关联

Association Between Serum 25-hydroxyvitamin D Concentrations and Mortality Among Adults With Prediabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该回顾性队列研究纳入NHANES III及2001-2014中15,195名≥20岁糖尿病前期成人,中位随访10.7年。血清25(OH)D≥75 nmol/L者较<30 nmol/L者全因死亡风险降低34%(HR 0.66),心血管死亡风险降低34%(HR 0.66),癌症死亡无显著关联。

要点

  • 糖尿病前期成人中仅23.1%维生素D充足(≥75 nmol/L)。
  • 25(OH)D≥75 nmol/L与全因及心血管死亡风险显著降低相关。
  • 25(OH)D与癌症死亡风险无显著关联。

核心结论

  • 较高的血清25(OH)D浓度与糖尿病前期成人较低的全因死亡和心血管死亡风险相关。

研究设计与样本

  • 回顾性队列研究,纳入NHANES III和NHANES 2001-2014中15,195名≥20岁糖尿病前期成人,中位随访10.7年。

主要发现

  • 血清25(OH)D中位浓度60.5 nmol/L(IQR 45.3-77.4),仅23.1%达到充足水平(≥75 nmol/L)。
  • 随访期间共3765例死亡,包括1080例心血管死亡和863例癌症死亡。
  • 与25(OH)D<30 nmol/L相比,≥75 nmol/L者全因死亡HR 0.66(95%CI 0.53-0.82,Ptrend<0.001),心血管死亡HR 0.66(95%CI 0.48-0.89,Ptrend=0.001),癌症死亡HR 0.82(95%CI 0.49-1.35,Ptrend=0.32)。
  • ln转换25(OH)D每增加一个单位,全因死亡风险降低27%,心血管死亡风险降低34%(均P<0.01)。
  • 基线时较高的25(OH)D与较低的胰岛素、HOMA-IR、甘油三酯和C反应蛋白水平及较高的高密度脂蛋白相关(所有Ptrend<0.05)。

临床怎么用

  • 对糖尿病前期成人可关注血清25(OH)D水平,低水平者可能需评估维生素D状态。
  • 纠正维生素D不足可能有助于降低全因和心血管死亡风险,但需干预研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the association of circulating 25-hydroxyvitamin D [25(OH)D] levels with mortality among adults with prediabetes. METHODS: This retrospective cohort study included 15,195 adults with prediabetes (aged ≥20 years) from the National Health and Nutrition Examination Survey (NHANES) III and NHANES 2001-2014. Mortality from all causes, cardiovascular disease (CVD), and cancer was linked to National Death Index mortality data. RESULTS: The median (interquartile range) concentration of serum 25(OH)D was 60.5 (45.3, 77.4) nmol/L, and only 23.1% had sufficient vitamin D (≥75 nmol/L). Elevated serum 25(OH)D concentrations were significantly associated with lower levels of insulin, homeostasis model assessment of insulin resistance, triglyceride, and C-reactive protein, and higher levels of high-density lipoprotein at baseline (all Ptrend < 0.05). During a median follow up of 10.7 years, 3765 deaths (including 1080 CVD deaths and 863 cancer deaths) were identified. Compared with participants with 25(OH)D <30 nmol/L, the multivariate-adjusted hazard ratios and 95% confidence intervals for participants with 25(OH)D ≥ 75 nmol/L were 0.66 (0.53, 0.82) for all-cause mortality (Ptrend < 0.001), 0.66 (0.48, 0.89) for CVD mortality (Ptrend = 0.001), and 0.82 (0.49, 1.35) for cancer mortality (Ptrend = 0.32). For per-unit increment in ln-transformed 25(OH)D, there was a 27% lower risk of all-cause mortality and a 34% lower risk of CVD mortality (both P < 0.01). CONCLUSIONS: These findings suggested that higher serum 25(OH)D concentrations were associated with lower all-cause and CVD mortality among individuals with prediabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lu Q, Wan Z, Guo J, et al. Association Between Serum 25-hydroxyvitamin D Concentrations and Mortality Among Adults With Prediabetes. J Clin Endocrinol Metab. 2021. PMID: 34089603. doi:10.1210/clinem/dgab402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。